ONDCP Seal
PolicyPolicy

Chapter II (continued)

6. MDMA

General — MDMA (3,4-methylenedioxymethamphetamine), commonly called ecstasy or XTC, is a synthetic, psychoactive drug possessing stimulant and mild hallucinogenic properties. The substance gained popularity in the late 1980s and early 1990s as an alternative to heroin and cocaine. MDMA customarily is sold and consumed at "raves," which are semi-clandestine, all-night parties and concerts. Use appears to be widespread within virtually every major U.S. city with indications of trafficking and abuse in smaller towns. MDMA is considered a "designer drug," which is a substance on the illegal market that is a chemical analogue or variation of another psychoactive drug. MDMA is similar in stimulant properties to amphetamine or methamphetamine, and it resembles mescaline in terms of hallucinogen qualities. Illicitly marketed as a "feel good" drug, it has been dubbed the "hug drug." Risks associated with MDMA include severe dehydration and death from heat stroke or heart failure.74 A review of several studies by the National Institute on Drug Abuse (NIDA) concludes that heavy MDMA users have significant impairments in visual and verbal memory compared to non-users.75 Further findings by Johns Hopkins University and the National Institute of Mental Health (NIMH) suggest that MDMA use may lead to impairment in other cognitive functions, such as the ability to reason verbally or sustain attention.76

Ecstasy (MDMA) and Our Youth
Trends in Annual Use

Chart

Source: 1999 Monitoring the Future Study

Overall Usage — Ecstasy is often used in conjunction with other drugs and is extremely popular among some teenagers and young professionals. Furthermore, growing numbers of users — primarily in the Miami and Orlando areas — combine MDMA with heroin, a practice known as "rolling." If this trend continues, MDMA may become a "gateway" drug that leads to the consumption of a variety of other substances. Emergency room mentions increased from sixty-eight in 1993 to 637 in 1997.77 MDMA also suppresses the need to eat, drink, or sleep and subsequently allows people to stay up all night, dancing at raves.78

Use among youth — According to the 1999 MTF, past-year use of MDMA increased from 3.3 percent in 1998 to 4.4 percent in 1999 among tenth graders. Twelfth grade use increased in all three categories by: 38 percent for lifetime use (5.8 percent to 8 percent), 56 percent for annual use (from 3.6 percent to 5.6 percent), and 67 percent for past 30-day use (from 1.5 percent to 2.5 percent) between 1998 and 1999.79 MDMA use is widespread, particularly among white adolescents in the Northeast.

Federal MDMA (Ecstasy) Seizures

Chart

Source: DEA, 1999 STRIDE Data

Availability — Numerous data reflect the increasing availability of MDMA in the United States — in metropolitan centers and suburban communities alike.80 Law-enforcement agencies report a surge in MDMA seizures between 1998 and 1999. The DEA seized more than 216,300 MDMA tablets in the United States in the first five months of 1999; the 1998 total was 143,600.81 The United States Customs Service (USCS) reports that seizures are up more than 700 percent since 1997. USCS seized three million MDMA tablets in fiscal year 1999 and two million to date in the first quarter of fiscal year 2000.82 Production of MDMA is centered in Europe (predominately Belgium, the Netherlands, and Luxembourg).83

Further encouraging the importation of MDMA to the United States is the drug's high profit margin — production costs are as low as two to twenty-five cents per dose while retail prices in the U.S. are between twenty dollars and forty-five dollars per dose.84 Increasing involvement of organized criminal groups — particularly Western European, Russian, and Israeli crime syndicates — indicates a move toward "professionalization" of MDMA markets. Law-enforcement reports indicate criminal groups that have proven capable of producing and smuggling significant quantities of MDMA into the United States are expanding distribution networks from coast to coast.85

Ecstasy (MDMA) Emergency Room Mentions

Chart

Source: SAMHSA, 1997 DAWN Emergency Department Data